Orthopedic Surgery Doctors in Southampton, PA Accepting Medicare

5 Orthopedic Surgery doctors found. Showing 1 - 5

Robert E Mannherz, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 283 Second Street Pike, Suite 120, Southampton, PA 18966 Phone: 215-355-7220    Fax: 215-355-7222

Todd D Schwartz, D.O. Orthopaedic Surgery - Adult Reconstructive Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 283 2nd Street Pike Ste 120, Southampton, PA 18966 Phone: 215-352-2663    Fax: 215-355-7222

David E Reinhardt, DO Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 260 Knowles Ave Ste 226, Southampton, PA 18966 Phone: 215-346-5252    Fax: 717-918-1852

Anthony W Salem, MD Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 283 Second Street Pike, Suite 120, Southampton, PA 18966 Phone: 215-355-7220    Fax: 215-355-7222

Leonard A Brody, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 283 Second Street Pike, Suite 120, Southampton, PA 18966 Phone: 215-355-7220    Fax: 215-355-7222

News Archive

Cyclacel announces completion of private placement sale

Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today that it consummated its previously announced private placement to sell approximately $15.2 million of its units to several institutional investors, including the Special Situations Funds, for net proceeds of approximately $14.1 million after the deduction of offering expenses.

RI Hospital researcher supports use of ablation procedures for treatment of lung cancer

The journal Radiology will publish in its September issue an article written by Damian E. Dupuy, M.D., director of tumor ablation at Rhode Island Hospital, supporting the use of ablation procedures for the treatment of lung cancer.

Barr Laboratories confirms Opana ER tablet patent challenge

Barr Pharmaceuticals, Inc. today confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Endo Pharmaceuticals Inc. in connection with its Opana(R) ER (oxymorphone hydrochloride) extended-release tablets, 5 mg, 10 mg, 20 mg and 40 mg.

Tips for parents to keep their kids safe while traveling in the car

In honor of National Child Passenger Safety Week Loyola University Health System safety expert offers tips on keeping children safe in the car. Car accidents remain the leading cause of death and disability in children in the United States. Stricter laws and car seat education programs have dramatically decreased the mortality and morbidity rates in motor vehicle accidents in the last several years. Yet, thousands of children die or are injured in car accidents each year.

Read more Medical News

› Verified 5 days ago